AngioDynamics (ANGO) vs SpyGlass Pharma (SGP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
SpyGlass Pharma is the larger company by market cap ($799.4 million vs $596.8 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANGO | SGP |
|---|---|---|
| Share price | $14.19 | $23.90 |
| Market cap | $596.75M | $799.41M |
| 1-day change | -1.60% | -3.55% |
| YTD return | +10.51% | — |
| 1-year return | +28.42% | — |
| 5-year return | -48.15% | — |
| EPS (TTM) | $-0.88 | $-2.51 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.29 | $32.44 |
| 52-week low | $9.39 | $17.06 |
| Distance from 52-week high | -12.89% | -26.33% |
| Average volume | 502.90K | 112.24K |
| Shares outstanding | 42.05M | 33.45M |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ANGO vs SGP FAQ
Which is bigger, AngioDynamics or SpyGlass Pharma?
SpyGlass Pharma (SGP) is larger, with a market capitalization of $799.41M compared with $596.75M for AngioDynamics (ANGO).
Are AngioDynamics and SpyGlass Pharma in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.